Dudediligence.

Johnson & Johnson

JNJNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$22.47BSep ’24$22.52BDec ’24$21.89BMar ’25$23.74BJun ’25$23.99BSep ’25$24.56BDec ’25$24.06BMar ’26$25.31BJun ’26
Net income, by quarter
$2.69BSep ’24$3.43BDec ’24$11.00BMar ’25$5.54BJun ’25$5.15BSep ’25$5.12BDec ’25$5.24BMar ’26$5.53BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$78.74B$79.99B$85.16B$88.82B$94.19B
Gross profit$55.34B$55.39B$58.61B$61.35B$63.94B
Net income$20.88B$17.94B$35.15B$14.07B$26.80B
Operating cash flow$23.41B$21.19B$22.79B$24.27B$24.53B
Free cash flow$19.76B$17.18B$18.25B$19.84B$19.70B
Cash$14.49B$12.89B$21.86B$24.11B$19.71B
Debt$33.75B$39.64B$29.33B$36.63B$47.93B
Shares outstanding3.12B3.12B3.12B3.12B3.12B